头孢洛林酯抗革兰阳性耐药菌应用研究进展
被引量:1
摘要
目的探讨抗革兰阳性耐药菌新型头孢菌素的研究进展。方法收集国外相关文献,对头孢洛林酯的化学结构、作用机制、抗菌活性、药效学、药动学、临床应用和不良反应进行分析和总结。结果与结论头孢洛林酯对革兰阳性耐药菌具有良好的抗菌活性,具有很好的应用前景。
出处
《中国药业》
CAS
2014年第19期123-124,共2页
China Pharmaceuticals
参考文献16
-
1Farrell D J, Flamm RK, Sader HS, et al. Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft - tissue infections in Europe (2010) [J]. Int J Antimicrob Agents, 2013,41 (4): 337 - 342.
-
2Lodise TP, Low DE. Ceftaroline fosamil in the treatment of community acquired bacterial pneumonia and acute bacterial skin and skin structure infections [ J ]. Drugs, 2012,72 ( 11 ) : 1 473 - 1 493.
-
3Saravolatz LD, Stein GE, Johnson LB. Ceftaroline: a novel cephalosporin with activity against methlciilin -resistant Staphylococcus aureus[J ]. Clin Infect Dis,2011,52(9): 1 156- 1 163.
-
4McGee L, Biek D, Ge Y, et al. In vitro evaluation of the antimicrobial activ- ity of ceftaroline against cephalosporin - resistant isolates of Streptococcus pneumoniae[J]. Antimicrob Agents Chemother,2009,53 (2): 552 -556.
-
5Ge Y, Biek D, Talbot GH, et al. In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States [ J ]. Antimicrob Agents Chemother, 2008,52 (9) : 3 398 - 3 407.
-
6Saravolatz L, Pawlak J, Johnson L. In vitro activity of ceftaroline against community - associated methicillin - resistant, vancomycin - intermediate, vancomycin - resistant, and daptomycin - nonsusceptiblc Staphylococcus au- reus isolates[J]. Antimicrob Agents Chemother,2010,54(7): 3 027 - 3 030. Citron DM, Tyrrell KL, Merriam CV, et al. In vitro activity of ceftaroline a- gainst 623 diverse strains.
-
7of anaerobic bacteria[J] . Antimicrob Agents Chemother,2010 .54(4): 1 627 - 1 632.
-
8Jacqueline C, Caillon J, Le Mabecque V, et al. In vivo efficacy of ceftaro- line (PPI- 0903), a new broad- spectrum cephalosporin, compared with linezolid and vancomycin against methicillin - resistant and vancomycin - intermediate Staphylococcus aureus in a rabbit endocarditis model[J]. Antimicrob Agents Chemother, 2007,51 (9): 3 397 - 3 400.
-
9Jaequeline C, Caillon J, Le Mabecque V, et al. In vivo activity of a novel anti- methieillin- resistant Staphylococcus aureus cephalosporin, cef- taroline, against vancomycin- susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid and vancomycin[J]. Antimicrob Agents Chemother,2009,53 ( 12): 5 300 - 5 302.
-
10Jacqueline C, Amador G, Caillon J, et al. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin - resistant Staphy- lococcus aureus acute osteomyelitis [ J ]. J Antimicrob Chemother, 2010, 65(8): 1 749 - 1 752.
同被引文献9
-
1朱庆义.加强临床微生物室药敏试验标准化与规范化的重要性[J].中华检验医学杂志,2006,29(5):390-392. 被引量:9
-
2黄胜炎.抗感染药新品及开发动向[J].上海医药,2011,32(10):517-518. 被引量:1
-
3王玉颖,王镇山,薛欣,聂大平.MRSA对万古霉素、替考拉宁和利奈唑胺体外诱导耐药性比较[J].大连医科大学学报,2012,34(3):257-261. 被引量:5
-
4赵爱慧,孙敬勇,姚庆强.3种最新抗耐甲氧西林金葡菌抗生素研究进展[J].食品与药品,2014,16(3):215-218. 被引量:2
-
5郑业焕,李轶,金湘东,荆鹏伟.多黏菌素B药敏条在肠杆菌科药敏检测中应用研究[J].中国抗生素杂志,2019,44(11):1312-1315. 被引量:2
-
6袁晓庆,王秀颖,李明,杨志华,谢建军,李全民.头孢洛林治疗金黄色葡萄球菌社区获得性肺炎的研究进展[J].临床肺科杂志,2020,25(5):782-785. 被引量:3
-
7刘岳峰,胡建华,刘红辉,廖国平,孙德贵.头孢洛林治疗儿童急性细菌感染性疾病的有效性与安全性的Meta分析[J].临床医药实践,2020,29(12):893-899. 被引量:2
-
8无.全国细菌耐药监测网2014—2019年不同等级医院细菌耐药监测报告[J].中国感染控制杂志,2021,20(2):95-111. 被引量:85
-
9单文雅.新型抗生素头孢洛林的研究进展[J].医疗装备,2016,29(6):188-189. 被引量:3
-
1刘美.抗革兰阳性耐药菌的新型头孢菌素类抗生素头孢洛林酯[J].中国新药杂志,2012,21(2):109-113. 被引量:6
-
2马帅,袁红,赵俊,曹胜华.新型广谱头孢菌素类抗生素头孢洛林酯[J].中国抗生素杂志,2015,40(2):145-153. 被引量:5
-
3单文雅.新型抗生素头孢洛林的研究进展[J].医疗装备,2016,29(6):188-189. 被引量:3
-
4邓燕.左氧氟沙星的临床应用进展[J].北方药学,2013,10(7):62-63. 被引量:11
-
5赵爱慧,孙敬勇,姚庆强.3种最新抗耐甲氧西林金葡菌抗生素研究进展[J].食品与药品,2014,16(3):215-218. 被引量:2
-
6单文卫,张藜莉,焦建辉,吕强.第5代头孢菌素头孢洛林酯的药理研究进展与临床应用评价[J].中国医院用药评价与分析,2012,12(1):3-5. 被引量:2
-
7安淑娟,蔡淑梅,金凤玲.产碳青霉烯酶泛耐药肠杆菌科细菌感染治疗药物的现况与未来[J].国际检验医学杂志,2014,35(4):446-449. 被引量:6
-
8杨方.第五代头孢类抗生素-头孢洛林酯研究进展[J].航空航天医学杂志,2015,26(1):92-93. 被引量:1
-
9万志龙,刘明亮,郭慧元.新的抗革兰阳性菌抗生素的药物经济学[J].国外医药(抗生素分册),2008,29(6):241-247. 被引量:4
-
10张翼.“第五代”头孢菌素类抗生素 头孢洛林酯获FDA批准全球首次上市[J].药品评价,2011,8(2):11-11. 被引量:2